Skip to content

Once a week protocol versus accelerated protocol of ESWT in chronic recalcitrant plantar fasciitis patients

Once a week protocol versus accelerated protocol of ESWT in chronic recalcitrant plantar fasciitis patients

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200424003
Enrollment
Unknown
Registered
2020-04-24
Start date
2018-03-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who diagnosed chronic recalcitrant plantar fasciitis and failed conservative treatment Chronic recalcitrant plantar fasciitis&#44

Interventions

accelerated protocol = an alternate day of ESWT * 5 times,standard protocol = once a week of ESWT * 5 times
Active Comparator Procedure/Surgery,Active Comparator Procedure/Surgery
Accelerated protocol of Extracorporeal shock wave therapy (ESWT) ,Standard protocol of Extracorporeal shock wave therapy (ESWT)

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) patients were older than 18 years old, (2) patients were diagnosed with plantar fasciitis more than 6 months prior with failed standard conservative treatments for 3 months (e.g. rest, activity modification, ice massage, nonsteroidal anti-inflammatory drugs, stretching, strengthening exercises), (3) the average pain of the patients in the last week was more than 3 on a visual analog scale (VAS), and (4) patients were able to complete SF-12 and American Orthopedic Foot and Ankle Society Score (AOFAS) Ankle-Hindfoot Scale questionnaires.

Exclusion criteria

Exclusion criteria: (1) a history of surgical interventions or recent foot and ankle trauma, (2) other foot and ankle pathologies including deformity, infection, (3) patients who received a corticosteroid injection at plantar fascia within 4 weeks, and (4) systemic diseases that contraindicate for ESWT such as hemophilia, coagulopathy, or foot and ankle malignancy.

Design outcomes

Primary

MeasureTime frame
VAS for pain 1.5 years Shapiro-Wilk normality test

Secondary

MeasureTime frame
SF-12, AOFAS Ankle-Hindfoot Scale 1.5 years paired t-test, Plantar fascia thickness 1.5 years Shapiro-Wilk normality test

Countries

Thailand

Contacts

Public ContactSarut Waranuchitkul

Department of Orthopaedic Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University

siethics@mahidol.ac.th024192667

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026